General Medical providers may have the opportunity to maximize patient quality of life by providing prescription opioids, yet those same medicines have contributed to the fact that drug overdose has overtaken motor vehicle crashes to be the #1 cause of injury death in the United States. Providers can consider taking the stance of “risky medicines”,Read More
Search Results for: prescribing and dispensing naloxone
Home
Welcome to prescribetoprevent.org! Here you will find information you need to start prescribing and dispensing naloxone (Narcan) rescue kits, including some useful resources containing further information about this life-saving medicine. We are prescribers, pharmacists, public health workers, lawyers, and researchers working on overdose prevention and naloxone access. We compiled these resources to help health careRead More
Substance Use Disorder Treatment
Engagement in substance use disorder treatment represents a potential paradox- while it can help individuals eliminate or reduce drug use, which can decrease overdose risk; it is also a tolerance changing event that can actually increase risk for overdose death. In March 2015, SAMHSA updated Opioid Treatment Program guidelines, including new guidance on discussing overdose:Read More
PubMed Update October 2019
Wow. 64 this month. Lots going on. Of note, several articles on pharmacists and on extended-release naltrexone. Plus the usual naloxone, buprenorphine, methadone papers. The following have been checked against all previous articles. 1) Overdose Education and Naloxone Distribution in the San Francisco County Jail. Wenger LD, Showalter D, Lambdin B, Leiva D, Wheeler E,Read More
PubMed Update February 2020
23 papers for the last pre-pandemic month on PubMed! Thanks again to Nicola Gerbino, Rebecca Martinez, Cathleen Beliveau, and Irene Liu at www.csuhsf.org for working on these summaries! 1) Association of Take-Home Naloxone and Opioid Overdose Reversals Performed by Patients in an Opioid Treatment Program. Katzman JG, Takeda MY, Greenberg N, Moya Balasch M, Alchbli A, KatzmanRead More
PubMed Update January 2020
Okay, we are WAY behind. And unfortunately a bit out of order. Skipping ahead to January 2020 for this round of 37 papers. Will try to wrap up 2019 next. Thanks again to Nicola Gerbino, Rebecca Martinez, Cathleen Beliveau, and Irene Liu at www.csuhsf.org for keeping this alive! 1) Commentary on Hoots et al. (2019): TheRead More
PubMed Update July 2019
Good month. 40 papers. I think the main takeaway here is the buprenorphine waiver required for U.S. providers to treat their patients with buprenorphine – it needs to go. It is an archaic and absurd construct essentially invented by the US Supreme Court a century ago when the court decided “addiction is not a disease”.Read More
PubMed Update June 2019
Oo – this was a good month! Wish I had seen these papers when they came out – 40 great articles addressing lots of medical management of overdose, as well as overdose prevention programs. Thanks again to Rebecca Martinez, Cathleen Beliveau, Nataliya Karashchuk, and Laila Esfandiari at the Center on Substance Use and Health (www.csuhsf.org)Read More
PubMed Update April 2019
After an unprecedented delay, we are thrilled to release the PubMed Updates through April of 2019 (26 papers). There is much work ahead to catch up and we hope to get 2 months out every month, catching up sometime later this year. Thanks to Rebecca Martinez, Cathleen Beliveau, Nataliya Karashchuk, and Laila Esfandiari at theRead More
PubMed Update September-November 2018
And thus went the autumn. 83 papers over the three months. 1) Infant and Youth Mortality Trends by Race/Ethnicity and Cause of Death in the United States. Khan SQ, Berrington de Gonzalez A, Best AF, Chen Y, Haozous EA, Rodriquez EJ, Spillane S, Thomas DA, Withrow D, Freedman ND, Shiels MS. JAMA Pediatr. 2018 Oct 1:e183317. doi: 10.1001/jamapediatrics.2018.3317. [Epub ahead of print] Comment: U.S. is not looking so good dueRead More